Comprehensive review of WJ-MSCs, their anti-inflammatory and immunomodulatory capabilities, and applications across various tissues.
Discusses UC-MSCs advantages over adult stem cells, especially for clinical use.
- “Intra-articular Injection of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase I/II Clinical Trial”
Stem Cells Translational Medicine, 2016
https://doi.org/10.5966/sctm.2015-0245
Demonstrated safety and early efficacy in using UC-MSCs for knee OA patients.
- “Wharton’s Jelly-Derived Mesenchymal Stem Cells for Cartilage Regeneration in Osteoarthritis: A Systematic Review and Meta-analysis”
Journal of Translational Medicine, 2021
https://doi.org/10.1186/s12967-021-02795-3
Meta-analysis confirms promising outcomes for WJ-MSCs in reducing pain and improving mobility.
- “Human Umbilical Cord-Derived Mesenchymal Stem Cell-Conditioned Media Promotes Hair Growth Through the Activation of Hair Follicle Dermal Papilla Cells”
Stem Cells International, 2021
https://doi.org/10.1155/2021/6691249
Demonstrated improved hair follicle activity and hair regeneration using umbilical cord-derived factors.
Highlights how UC-MSC exosomes trigger signaling pathways essential to follicle growth.
Showed improved healing, skin remodeling, and collagen formation in wound sites.
Discusses aesthetic benefits of stem cell-derived exosomes (including UC source) for anti-aging and dermatologic applications.
WJ-MSCs shown to reduce inflammatory markers and regulate immune responses—ideal for degenerative and autoimmune conditions.